TLDR Regenerative medicine in Malaysia shows promise for treating diseases but faces ethical and safety challenges.
The document reviewed the state of regenerative medicine therapy (RMT) in Malaysia, highlighting its potential in tissue and organ regeneration, with a focus on stem cell therapy, tissue engineering, and biomaterials. It noted the growth of medical tourism, with 1.3 million medical tourists in 2019, and discussed applications in treating diseases and aesthetic conditions like alopecia. Despite promising developments, challenges such as cultural diversity, limited clinical evidence, and regulatory gaps were noted. The document emphasized the need for more detailed regulations and highlighted ongoing research and clinical trials, particularly in blood cancer treatment using hematopoietic stem cells. While Malaysia was behind other developed nations, it was making progress in RMT research and applications.
1036 citations
,
August 2019 in “Cells” Mesenchymal stem cells can help repair body tissues with low risk of rejection.
100 citations
,
April 2010 in “Expert Opinion on Pharmacotherapy” Hair loss in men treated best with early medication or transplant, new treatments researched.
15 citations
,
January 2014 in “BioMed Research International” Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.
14 citations
,
November 2020 in “International Journal of Molecular Sciences” Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.
16 citations
,
April 2021 in “Frontiers in Cell and Developmental Biology” New hair follicles could be created to treat hair loss.
October 2025 in “Cell Transplantation” New hair loss treatments like stem cells and gene therapy show promise but need more research for safety and effectiveness.
76 citations
,
February 2021 in “International Journal of Molecular Sciences” Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.
